RISK FACTORS FOR VISUAL LOSS IN GIANT CELL ARTERITIS (GCA)

被引：0

作者：

Solans-Laque, R. ^{[1
]}

Fraile, G. ^{[2
]}

Escalante, B. ^{[3
]}

Fonseca, E. ^{[4
]}

Martinez-Zapico, A. ^{[5
]}

Perez-Conesa, M. ^{[6
]}

Abdilla, M. ^{[7
]}

Montegaudo, M. ^{[8
]}

Caminal, L. ^{[5
]}

Gracia, B. ^{[3
]}

Del Castillo, M. J. ^{[9
]}

Fanlo, P. ^{[10
]}

Ramentol, M. ^{[1
]}

机构：

[1] H Vall hebron, Internal Med, Barcelona, Spain

[2] Hosp Ramon & Cajal, Internal Med, Madrid, Spain

[3] H Clin, Internal Med, Zaragoza, Spain

[4] H Cabuenes, Internal Med, Asturias, Spain

[5] HUCA, Internal Med, Asturias, Spain

[6] H Miguel Servet, Internal Med, Zaragoza, Spain

[7] H Ribera, Internal Med, Valencia, Spain

[8] H Parc Tauli, Internal Med, Sabadell, Spain

[9] H Virgen Rocio, Internal Med, Seville, Spain

[10] Clin Navarra, Internal Med, Navarra, Spain

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷

关键词：

D O I：

10.1136/annrheumdis-2016-eular.5355

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

SAT0365

引用

页码：799 / 799

页数：1

共 50 条

[1] Risk factors for visual loss and stroke in patients with giant cell arteritis
Nesher, G
Berkum, Y
Mates, M
Baras, M
Nesher, R
Rubinow, A
Sonnenblick, M
ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S206 - S206
[2] The association of vascular risk factors with visual loss in giant cell arteritis
Yates, Max
MacGregor, Alex J.
Robson, Joanna
Craven, Anthea
Merkel, Peter A.
Luqmani, Raashid A.
Watts, Richard A.
RHEUMATOLOGY, 2017, 56 (04) : 524 - 528
[3] Risk for Visual Loss in Patients with Giant Cell Arteritis
Haaversen, Anne Bull
Brekke, Lene Kristin
Kermani, Tanaz
Molberg, Oyvind
Diamantopoulos, Andreas
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 985 - 986
[4] Visual loss in giant cell arteritis
Gordon, LK
Levin, LA
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (04): : 385 - 386
[5] Visual loss and giant cell arteritis
Docken, WP
BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (07): : 823 - 823
[6] VISUAL INVOLVEMENT AND PERMANENT VISUAL LOSS IN GIANT CELL ARTERITIS: PREDICTIVE FACTORS
Sanchez-Bilbao, L.
Loricera, J.
Moriano, C.
Castaneda, S.
Ferraz-Amaro, I.
Narvaez, J.
Aldasoro, V.
Maiz, O.
Melero, R.
Villa-Blanco, I.
Vela-Casasempere, P.
Romero-Yuste, S.
Callejas-Rubio, J. L.
De Miguel, E.
Galindez-Agirregoikoa, E.
Sivera, F.
Fernandez-Lopez, C.
Galisteo, C.
Sanchez-Martin, J.
Calderon-Goercke, M.
Hernandez, J. L.
Gonzalez-Gay, M. A.
Blanco, R.
Tocilizumab In Giant Cell Arteritis
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 688 - 689
[7] Treatment of Giant Cell Arteritis (GCA)
Regent, Alexis
Mouthon, Luc
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
[8] Visual hallucinations and the risk of visual loss in patients with giant cell (temporal)arteritis
Liozon, E
Ly, K
Loustaud, V
Vidal, E
JOURNAL OF RHEUMATOLOGY, 2002, 29 (04) : 855 - 857
[9] Risk factors for visual loss in giant cell (Temporal) arteritis: A prospective study of 174 patients
Liozon, E
Herrmann, F
Ly, K
Robert, PY
Loustaud, V
Soria, P
Vidal, E
AMERICAN JOURNAL OF MEDICINE, 2001, 111 (03): : 211 - 217
[10] FACTORS INVOLVED IN THE PERSISTENCE OF INFLAMMATORY LESIONS IN GIANT CELL ARTERITIS (GCA)
Cid, M. C.
RHEUMATOLOGY, 2005, 44 : 8 - 9

← 1 2 3 4 5 →